≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Benign neoplasm: Larynx

DOID EFO Endpoint Browser PheWeb

CD2_BENIGN_LARYNX

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D14.1&
  • Hospital discharge: ICD-9 — 2121
  • Hospital discharge: ICD-8 — 2121
  • Cause of death: ICD-10 — D14.1&
  • Cause of death: ICD-9 — 2121
  • Cause of death: ICD-8 — 2121

2 out of 7 registries used, show all original rules.

1179

4. Check minimum number of events

None

1179

5. Include endpoints

None

1179

6. Filter based on genotype QC (FinnGen only)

1179

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D14
Name in latin
Neoplasma benignum laryngis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 7637 2657 4895
Only index persons 6316 2327 3989
Unadjusted period prevalence (%)
Whole population 0.12 0.08 0.14
Only index persons 0.13 0.09 0.15
Median age at first event (years)
Whole population 55.93 55.72 55.94
Only index persons 54.31 54.47 54.22

-FinnGen-

Key figures

All Female Male
Number of individuals 1179 386 793
Unadjusted period prevalence (%) 0.28 0.13 0.35
Median age at first event (years) 56.07 52.05 58.04

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1075
Matched controls
10751
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
DQB10
NOMESCO Finland
Endoscopic excision of lesion of larynx
228.5
323.0
411
29
D14.1
ICD-10 Finland
Benign neoplasm: Larynx
+∞
323.0
907
*
UDQ22
NOMESCO Finland
Microlaryngoscopy
192.9
260.3
263
18
UDQ12
NOMESCO Finland
Flexible laryngoscopy
17.7
189.1
313
244
DQA10
NOMESCO Finland
Biopsy of larynx
238.1
178.1
179
9
ZXC10
NOMESCO Finland
Use of laser
26.7
134.3
189
85
C32.0
ICD-10 Finland
Malignant neoplasm: Glottis
129.5
128.4
136
12
D38.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Larynx
136.1
114.7
121
10
21210
ICD-8 Finland
Benign neoplasm of respiratory system, Larynx
+∞
111.4
105
*
B97.7
ICD-10 Finland
Papillomavirus as the cause of diseases classified to other chapters
210.1
110.8
113
6
2121A
ICD-9 Finland
Benign neoplasm of respiratory and intrathoracic organs, Larynx
+∞
104.9
99
*
J38.3
ICD-10 Finland
Other diseases of vocal cords
41.4
99.7
125
34
1420
FHL
Laryngomicroscopy
50.9
94.7
114
25
J37.0
ICD-10 Finland
Chronic laryngitis
15.2
91.0
156
119
J38.1
ICD-10 Finland
Polyp of vocal cord and larynx
41.8
84.8
106
28
UDQ02
NOMESCO Finland
Direct laryngoscopy
43.5
71.0
88
22
8070/3-C32.0
ICD-O-3
Squamous cell carcinoma, NOS, of glottis
120.8
63.6
68
6
8070/3-C32.9
ICD-O-3
Squamous cell carcinoma, NOS, of larynx, NOS
120.2
53.3
57
5
UJC01
NOMESCO Finland
Scopy of lower throat
19.8
50.0
76
41
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
45.3
45.8
56
13
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
41.3
381
1842
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.0
40.2
282
1149
R49.0
ICD-10 Finland
Dysphonia
15.2
39.5
66
46
C32.9
ICD-10 Finland
Malignant neoplasm: Larynx, unspecified
106.5
38.0
41
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
4.7
37.3
137
327
WX734
NOMESCO Finland
JET-ventilation
369.1
36.2
36
*
C32.1
ICD-10 Finland
Malignant neoplasm: Supraglottis
191.3
36.0
37
*
C32.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of larynx
186.0
35.0
36
*
R49.08
ICD-10 Finland
Other specified dysphonia
11.7
34.6
65
59
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
10.3
34.5
69
71
B977, D141
ICD-10 Finland
NA
+∞
33.5
32
*
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
17.8
32.6
51
30
DQB30
NOMESCO Finland
Laryngectomy
+∞
32.5
31
*
A02BC05
ATC
esomeprazole; systemic
2.2
31.5
480
2891
J38.7
ICD-10 Finland
Other diseases of larynx
164.7
30.8
32
*
ZXE00
NOMESCO Finland
One hour or less
2.2
30.7
479
2909
R49.01
ICD-10 Finland
Functional dysphonia
7.9
30.5
71
95
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.5
30.3
156
501
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
19.2
30.3
46
25
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.6
29.3
106
248
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
27.2
459
2833
DQE00
NOMESCO Finland
Implantation of prosthetic replacement for larynx
143.6
26.7
28
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
10.0
25.4
51
53
DQB70
NOMESCO Finland
Total excision of vocal cord
127.8
23.7
25
*
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
3.2
23.2
130
441
R13
ICD-10 Finland
Dysphagia
3.6
23.2
112
340
J38.2
ICD-10 Finland
Nodules of vocal cords
26.5
22.7
31
12
A02BC02
ATC
pantoprazole; systemic
1.9
22.4
697
5276
H02AB06
ATC
prednisolone; systemic
1.8
19.6
516
3610
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.4
18.9
173
789
GB3AV
NOMESCO Finland
NA
101.8
18.6
20
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
7.8
18.0
41
54
R07.0
ICD-10 Finland
Pain in throat
3.5
17.7
84
251
WX402
NOMESCO Finland
General anaesthesia
2.2
17.6
192
952
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
4.3
17.5
65
157
UJC02
NOMESCO Finland
Rigid oesophagoscopy
8.3
16.9
37
46
4760A
ICD-9 Finland
Chronic laryngitis and laryngotracheitis, Chronic laryngitis
91.5
16.6
18
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
7.2
16.2
39
56
WF002
NOMESCO Finland
Radical radiotherapy
3.2
16.2
89
298
GBB00
NOMESCO Finland
Tracheostomy
7.1
16.0
39
57
R49.09
ICD-10 Finland
Unspecified dysphonia
11.0
15.5
29
27
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
15.4
392
2653
R49.8
ICD-10 Finland
Other and unspecified voice disturbances
10.6
15.3
29
28
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
15.0
326
2094
1430
FHL
Laryngoscopy (direct)
57.5
14.8
17
*
A02BC03
ATC
lansoprazole; oral
1.8
14.8
316
2018
4509
FHL
Other measure in this category
151.9
14.5
15
*
D10.7
ICD-10 Finland
Benign neoplasm: Hypopharynx
151.9
14.5
15
*
R03BB04
ATC
tiotropium bromide; inhalant
2.2
13.9
145
698
R03AC02
ATC
salbutamol; inhalant
1.6
13.8
508
3787
J01DA01
ATC
[U] cefalexin; systemic
1.6
13.8
645
5131
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
12.9
489
3653
J01AA02
ATC
doxycycline; systemic
1.7
12.6
786
6665
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.4
12.2
105
460
130
Kela drug reimbursment
Malignant tumour
2.2
11.9
121
576
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.8
11.9
77
288
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
11.8
463
3462
DQE10
NOMESCO Finland
Injection of foreign material into vocal cord
30.4
11.7
15
5
C14.1
ICD-10 Finland
Malignant neoplasm of laryngopharynx unspecified
+∞
11.5
11
*
8070/3-C32.1
ICD-O-3
Squamous cell carcinoma, NOS, of supraglottis
121.2
11.4
12
*
EBA15
NOMESCO Finland
Extraction of large number of teeth
3.3
11.2
56
176
A02BC01
ATC
omeprazole; systemic
1.7
11.2
292
1951
N07BA03
ATC
varenicline; oral
3.0
11.0
63
217
GBB13
NOMESCO Finland
Revision of tracheostomy
43.8
10.9
13
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
6.1
10.9
29
49
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.9
10.9
160
889
UJF32
NOMESCO Finland
Coloscopy
1.7
10.8
270
1781
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.6
10.8
78
310
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
5.3
10.8
32
62
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
10.8
333
2328
R06.0
ICD-10 Finland
Dyspnoea
1.7
10.6
252
1639
N02AA05
ATC
oxycodone; systemic
1.9
10.6
170
974
ENA10
NOMESCO Finland
Biopsy of pharynx
16.2
10.4
16
10
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
10.3
278
1871
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
8.9
10.3
21
24
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
23.6
10.3
14
6
UDC00
NOMESCO Finland
Ear microscopy
2.4
10.2
87
382
A07AA02
ATC
nystatin; oral
2.5
10.1
78
325
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
10.0
372
2716
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
40.4
10.0
12
*
4784A
ICD-9 Finland
Other diseases of upper respiratory tract, Polyp of vocal cord or larynx[POLYPUS PLICAE VOCALIS]
16.9
9.9
15
9
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
9.8
218
1386
Z50.5
ICD-10 Finland
Speech therapy
5.6
9.7
27
49
50808
ICD-8 Finland
Other diseases of upper respiratory tract, Alii definiti
13.5
9.7
16
12
8070/2-C32.0
ICD-O-3
Squamous cell carcinoma in situ, NOS, of glottis
100.9
9.4
10
*
D10.5
ICD-10 Finland
Benign neoplasm: Other parts of oropharynx
30.3
9.4
12
*
A03FA01
ATC
metoclopramide; systemic, rectal
1.7
9.3
205
1295
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
3.0
9.3
54
189
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
9.2
169
1009
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
9.2
312
2217
H02AB04
ATC
methylprednisolone; systemic
1.9
9.1
148
849
ZXB10
NOMESCO Finland
Medial
6.9
8.9
21
31
R23
ICPC
Voice symptom/complaint
5.2
8.8
26
51
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
7.3
8.8
20
28
ZXA05
NOMESCO Finland
Left side
1.6
8.7
260
1788
ZXD20
NOMESCO Finland
Day surgery
1.9
8.7
137
777
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
8.6
212
1384
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.4
8.6
72
315
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.5
8.3
64
267
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
2.2
8.3
80
374
J02AC01
ATC
fluconazole; systemic
1.5
8.0
303
2195
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
6.6
7.9
19
29
XX3DW
NOMESCO Finland
Time consuming IT work
2.0
7.9
107
574
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
10.9
7.8
14
13
R21
ICPC
Throat symptom/complaint
1.8
7.8
145
869
J38.4
ICD-10 Finland
Oedema of larynx
15.1
7.7
12
8
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
5.6
7.7
21
38
J01FA10
ATC
azithromycin; systemic
1.4
7.7
495
4003
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
7.6
192
1256
R53
ICD-10 Finland
Malaise and fatigue
1.6
7.6
186
1211
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
7.6
166
1046
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
6.2
7.6
19
31
R95
ICPC
Chron obstructive pulmonary disease
3.0
7.5
41
140
N05BA01
ATC
diazepam; systemic, rectal
1.8
7.5
136
809
J01DB01
ATC
cefalexin; oral
1.5
7.4
789
7002
J20
ICD-10 Finland
Acute bronchitis
2.0
7.4
88
451
A02BA02
ATC
ranitidine; systemic
1.6
7.4
204
1367
J01CA04
ATC
amoxicillin; systemic
1.5
7.3
754
6639
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
7.3
204
1373
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
6.3
7.3
18
29
R03BA05
ATC
fluticasone; inhalant
1.7
7.2
162
1028
D02.0
ICD-10 Finland
Carcinoma in situ: Larynx
30.2
7.2
9
*
ZXA10
NOMESCO Finland
Bilateral
1.6
7.2
180
1179
J01FA06
ATC
roxithromycin; oral
1.4
7.1
370
2857
J39.2
ICD-10 Finland
Other diseases of pharynx
5.7
7.1
19
34
J01MA12
ATC
levofloxacin; systemic
1.6
7.0
196
1319
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
3.0
6.9
38
131
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
4.8
6.9
21
44
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.9
6.9
99
545
N02BE01
ATC
paracetamol; systemic, rectal
1.5
6.8
836
7553
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
6.8
362
2799
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
5.4
6.8
19
36
R04.2
ICD-10 Finland
Haemoptysis
2.5
6.8
49
200
C320, 8077, 2
ICD-O-3
NA
40.3
6.8
8
*
C13.9
ICD-10 Finland
Malignant neoplasm: Hypopharynx, unspecified
40.3
6.8
8
*
N02AX02
ATC
tramadol; systemic, rectal
1.4
6.7
416
3315
M01AE01
ATC
ibuprofen; systemic, rectal
1.5
6.7
856
7778
R4130
NOMESCO Finland
Speech therapy
3.2
6.7
32
101
J04.0
ICD-10 Finland
Acute laryngitis
3.5
6.6
29
85
UGB02
NOMESCO Finland
Tracheoscopy
12.3
6.6
11
9
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
12.3
6.6
11
9
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
8.8
6.6
13
15
GD1AD
NOMESCO Finland
Thorax CT examination
2.4
6.6
55
240
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.0
6.5
79
409
J01CE02
ATC
phenoxymethylpenicillin; oral
1.4
6.5
634
5461
C32.2
ICD-10 Finland
Malignant neoplasm: Subglottis
70.2
6.4
7
*
J38.6
ICD-10 Finland
Stenosis of larynx
70.2
6.4
7
*
P01AB01
ATC
metronidazole; oral, rectal
1.4
6.4
329
2527
H02AB07
ATC
prednisone; oral
1.7
6.4
145
921
M02AA07
ATC
piroxicam; topical
1.4
6.3
343
2657
UJC12
NOMESCO Finland
Flexible oesophagoscopy
6.0
6.3
16
27
WX400
NOMESCO Finland
Inhalation anesthesy
2.7
6.3
41
157
UGC02
NOMESCO Finland
Rigid bronchoscopy
18.1
6.3
9
5
DQB00
NOMESCO Finland
Excision of lesion of larynx
+∞
6.3
6
*
D14.2
ICD-10 Finland
Benign neoplasm: Trachea
+∞
6.3
6
*
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.7
6.2
131
815
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
5.8
6.2
16
28
M54.5
ICD-10 Finland
Low back pain
1.5
6.1
272
2027
H03AA01
ATC
levothyroxine sodium; systemic
1.6
6.1
178
1208

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768804) Tissue Pathology biopsy report
560
3497
2.15
35.47
2.9
2.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
222
1354
1.79
12.58
20.2
25.9
inr
1.3
1.4
0.10
52
188
(3012095) Magnesium [Moles/volume] in Serum or Plasma
247
1570
1.73
12.08
4.5
3.6
mmol/l
0.8
0.8
2.01
237
1468
(3013650) Neutrophils [#/volume] in Blood by Automated count
644
5212
1.52
11.05
8.8
9.3
e9/l
4.3
4.2
0.21
572
4528
(3006315) Basophils [#/volume] in Blood
569
4513
1.50
10.57
5.9
5.9
e9/l
0.0
0.0
0.03
496
3874
(3024561) Albumin [Mass/volume] in Serum or Plasma
521
4059
1.51
10.55
4.7
5.2
g/l
34.8
35.0
0.36
481
3787
(3019198) Lymphocytes [#/volume] in Blood
577
4609
1.49
10.24
6.0
6.0
e9/l
2.1
2.0
0.34
513
4045
(4035726)
142
806
1.87
10.07
1.4
1.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
582
4670
1.49
10.02
6.1
6.2
e9/l
0.2
0.2
1.25
519
4100
(3002582) Erythrocytes [#/volume] in Urine
395
2931
1.52
9.94
3.6
3.4
e6/l
36.0
94.0
1.60
312
2290
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
821
7083
1.52
9.76
8.6
7.8
u/l
82.9
80.0
0.36
775
6636
(3001604) Monocytes [#/volume] in Blood
561
4497
1.47
9.54
5.9
5.9
e9/l
0.6
0.6
0.61
488
3852
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
601
4898
1.46
9.30
6.6
6.6
umol/l
12.6
12.1
0.17
570
4652
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
453
3515
1.47
8.93
3.7
3.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
434
3344
1.47
8.85
3.9
3.9
e6/l
38.0
124.8
2.30
329
2448
(3006504) Eosinophils/100 leukocytes in Blood
531
4255
1.45
8.81
6.3
6.1
%
2.7
2.9
1.19
500
3955
(3013826) Glucose [Moles/volume] in Serum or Plasma
669
5614
1.44
8.57
5.0
5.2
mmol/l
6.6
6.8
1.70
650
5279
(3002030) Lymphocytes/100 leukocytes in Blood
540
4360
1.44
8.50
6.3
6.2
%
26.8
27.0
0.11
504
4051
(3019069) Monocytes/100 leukocytes in Blood
530
4271
1.44
8.40
6.5
6.4
%
8.9
8.9
0.03
501
3989
(40768797) Stomach Pathology biopsy report
191
1244
1.64
8.30
1.3
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
181
1163
1.66
8.29
1.8
1.8
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
287
2057
1.52
8.25
2.9
2.6
e6/l
4.1
4.5
0.25
241
1810
(3022096) Basophils/100 leukocytes in Blood
514
4135
1.43
8.15
6.2
6.1
%
0.6
0.7
1.09
481
3849
(3018010) Neutrophils/100 leukocytes in Blood
529
4282
1.43
8.08
6.2
6.0
%
58.4
57.8
0.52
497
4004
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
77
383
2.08
7.99
2.5
2.9
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
40
149
2.74
7.89
1.1
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
530
4311
1.42
7.79
4.5
4.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
401
3107
1.44
7.69
5.9
6.0
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
695
5960
1.40
7.35
5.4
4.4
e6/l
369.1
1482.3
0.70
14
96
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
563
4670
1.39
7.18
6.7
7.2
mmol/l
1.2
1.2
0.17
467
3938
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
744
6474
1.40
7.10
4.2
3.6
pmol/l
15.0
14.8
0.78
666
5805
(3013707) Erythrocyte sedimentation rate by Westergren method
764
6681
1.41
7.07
4.8
4.0
mm/h
13.6
12.8
0.77
715
6132
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
233
1653
1.51
6.91
2.1
1.9
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
519
4298
1.37
6.46
5.7
6.4
mmol/l
1.2
1.2
0.30
483
3896
(3030467) Casts [#/volume] in Urine by Automated count
345
2670
1.41
6.45
3.4
3.3
e6/l
0.3
0.5
1.80
257
2041
(3002256) Pathology report gross observation
172
1172
1.55
6.11
1.4
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
151
1005
1.58
5.95
4.6
3.7
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
369
2924
1.38
5.91
2.8
2.6
u/l
55.9
56.7
0.17
342
2708
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
593
5060
1.35
5.89
2.9
2.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
469
3865
1.35
5.85
2.0
2.0
pmol/l
95.6
93.5
0.44
254
2049
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
71
392
1.86
5.54
2.2
1.9
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
306
2376
1.39
5.48
2.3
2.1
mg/l
3.0
3.1
0.11
273
2021
(3033658) Prothrombin time (PT) actual/Normal
307
2403
1.38
5.20
3.7
4.1
%
87.2
86.9
0.08
300
2354
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
877
8018
1.37
5.10
5.2
4.4
mu/l
2.1
2.1
0.13
800
7242
(36304419) Bacteria [Presence] in Urine
324
2572
1.36
5.00
3.5
3.3
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
39
181
2.19
4.92
1.1
1.2
—
36.0
—
0
5
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
43
208
2.11
4.89
1.3
1.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
379
3092
1.33
4.85
3.2
3.5
mmol/l
2.4
2.3
0.21
334
2691
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
249
1908
1.39
4.77
4.1
4.0
ng/l
315.7
330.7
0.05
191
1570
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
230
1741
1.40
4.73
2.7
3.2
mmol/l
2.5
2.4
1.11
200
1532
(3023419) Bacteria identified in Sputum by Culture
32
140
2.32
4.64
2.3
2.6
—
—
—
0
0
(3013512) EKG study
345
2807
1.32
4.44
4.7
4.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
350
2861
1.32
4.34
4.4
4.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
81
501
1.66
4.33
5.5
3.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
963
9015
1.37
4.23
20.1
15.9
mg/l
24.7
26.5
1.00
836
7269
(3000494) Fungus identified in Specimen by Culture
154
1106
1.45
4.23
1.5
1.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
159
1150
1.44
4.21
2.1
2.6
%
1.8
1.8
0.26
148
1036
(40761536) Microorganisms panel - Urine sediment
113
764
1.53
4.17
4.0
3.9
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
89
570
1.61
4.16
1.6
1.6
g/l
1.4
1.5
0.17
83
531
(3037467) Urinalysis macro (dipstick) panel - Urine
698
6264
1.28
4.12
5.0
4.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
193
1451
1.39
4.11
1.8
2.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
62
362
1.75
4.09
2.3
1.7
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
103
689
1.54
4.00
5.7
3.8
kpa
5.3
5.1
1.27
96
643
(3018418) pH of Serum or Plasma
338
2780
1.30
3.95
4.2
4.1
ph
7.4
7.4
0.08
76
525
(3032080) INR in Blood by Coagulation assay
474
4071
1.27
3.95
9.4
10.5
inr
1.3
1.3
0.49
137
1140
(3044889) 12 lead EKG panel
721
6516
1.27
3.93
4.7
4.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
43
227
1.93
3.91
4.4
5.4
mmol/l
2.7
2.4
0.24
29
152
(3044640) Blood type and Crossmatch panel - Blood
359
2980
1.29
3.91
2.4
2.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
24
100
2.43
3.91
1.9
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
133
945
1.46
3.87
2.9
2.3
ug/g
166.9
137.9
0.24
102
757
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
43
228
1.92
3.87
1.6
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
209
1609
1.36
3.85
1.4
1.4
g/l
2.8
2.6
0.32
141
991
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
149
1085
1.43
3.81
2.5
2.9
umol/l
11.7
8.9
0.27
130
969
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
97
649
1.54
3.77
5.6
3.8
mmol/l
2.0
1.8
0.17
81
487
(3010421) pH of Blood
49
274
1.82
3.75
4.0
4.9
ph
7.4
7.4
2.48
42
223
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
90
593
1.56
3.75
6.5
8.8
mmol/l
25.5
24.8
1.29
90
588
(3001122) Ferritin [Mass/volume] in Serum or Plasma
433
3702
1.27
3.68
3.0
2.8
ug/l
156.0
155.2
0.01
410
3388
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
48
269
1.82
3.66
1.7
1.6
—
—
—
0
0
(3009343) pH of Capillary blood
100
679
1.52
3.64
5.7
3.8
ph
7.4
7.4
0.85
11
84
(1616796) Gas panel - Central venous blood
41
219
1.90
3.62
4.2
4.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
347
2893
1.28
3.61
2.4
2.2
u/l
194.1
247.9
0.76
332
2720
(40760892) CBC W Ordered Manual Differential panel - Blood
243
1933
1.32
3.59
4.2
4.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
125
892
1.45
3.57
3.0
2.6
ug/l
5.0
7.2
1.44
115
787
(3021901) Oxygen saturation in Capillary blood
38
199
1.94
3.56
3.9
3.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
282
2294
1.30
3.54
2.4
2.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
34
172
2.01
3.51
3.5
3.2
e9/l
4.4
4.5
0.10
34
172
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
35
180
1.97
3.46
3.8
3.5
%
60.2
57.7
0.52
35
180
(3005719) IgG [Mass/volume] in Serum or Plasma
103
713
1.49
3.43
2.1
2.6
g/l
10.2
10.8
0.58
97
655
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
211
1659
1.33
3.37
2.9
2.9
e6/l
0.9
0.9
0.13
119
981
(3019309) Folate [Moles/volume] in Red Blood Cells
230
1834
1.32
3.33
1.7
1.8
nmol/l
1261.1
1158.6
0.82
182
1364
(3019550) Sodium [Moles/volume] in Serum or Plasma
991
9404
1.34
3.31
21.6
18.5
mmol/l
139.5
139.7
1.56
975
9157
(3004809) Band form neutrophils/100 leukocytes in Blood
31
156
2.01
3.27
1.8
3.7
%
2.0
1.4
0.30
21
130
(3004789) Transferrin [Mass/volume] in Serum or Plasma
182
1410
1.34
3.21
2.2
2.5
g/l
2.4
2.3
1.15
176
1318
(3004616) Nuclear Ab [Presence] in Serum
21
91
2.33
3.18
1.2
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
200
1574
1.33
3.17
3.2
3.1
e6/l
1.8
1.4
0.32
109
902
(3023520) Reticulocytes [#/volume] in Blood
117
849
1.42
3.07
2.7
2.8
e9/l
74.4
69.9
0.70
95
662
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1006
9591
1.33
3.06
12.0
10.8
u/l
27.5
27.4
0.03
978
9237
(3026782) Osmolality of Urine
238
1934
1.29
2.98
3.1
2.8
mosm/kgh2o
546.5
568.3
0.87
205
1636
(3023103) Potassium [Moles/volume] in Serum or Plasma
990
9426
1.31
2.97
21.8
18.7
mmol/l
4.0
4.0
0.31
974
9170
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
157
1205
1.35
2.95
1.7
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
179
1401
1.33
2.95
1.2
1.3
iu/ml
49.4
35.9
0.29
54
438
(3022948) Iron [Moles/volume] in Serum or Plasma
192
1520
1.31
2.92
2.2
2.6
umol/l
11.9
13.0
1.24
182
1418
(3009261) Glucose [Presence] in Urine by Test strip
500
4430
1.22
2.91
3.8
3.6
estimate
0.0
0.0
0.50
103
784
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
244
1996
1.28
2.89
1.7
1.7
mg/l
0.9
1.3
3.38
193
1561
(3021601) Nitrite [Presence] in Urine by Test strip
493
4367
1.22
2.86
4.7
4.8
estimate
0.0
0.0
0.00
106
827
(3018677) aPTT in Platelet poor plasma by Coagulation assay
191
1517
1.31
2.83
1.8
2.1
s
29.6
30.0
0.37
185
1468
(40758558) Short blood count panel - Blood
275
2293
1.26
2.78
7.0
6.7
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
169
1324
1.32
2.77
5.0
6.1
mmol/l
1.0
1.0
0.18
157
1224
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
169
1325
1.32
2.75
2.3
2.6
%
21.4
23.2
0.83
149
1142
(3029937) Albumin [Presence] in Urine by Test strip
286
2400
1.25
2.73
4.3
4.0
estimate
0.0
0.0
0.69
101
790
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
402
3501
1.22
2.73
2.2
2.2
nmol/l
75.7
76.2
0.14
369
3094
(3045414) Leukocytes [Presence] in Urine
60
390
1.57
2.72
2.0
1.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
158
1236
1.32
2.62
1.7
1.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
115
857
1.38
2.61
3.3
3.0
ng/l
412.0
218.5
0.49
104
775
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
344
2960
1.23
2.60
3.3
3.1
ng/l
1172.4
1712.4
2.66
299
2537
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
68
461
1.50
2.56
2.5
2.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
429
3781
1.21
2.55
4.8
3.8
ng/l
43.4
57.5
0.45
317
2770
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
899
8510
1.24
2.50
17.4
14.6
ml/min/173m2
80.2
78.6
1.36
781
7054
(3015235) Bicarbonate [Moles/volume] in Capillary blood
45
279
1.64
2.49
4.8
3.1
mmol/l
25.5
24.7
0.55
37
242
(3037522) Nuclear Ab [Titer] in Serum
146
1138
1.32
2.49
1.4
1.3
titre
469.1
453.0
0.05
33
246
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
152
1192
1.32
2.48
5.7
8.3
kpa
5.2
5.1
0.12
147
1143
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
9
26
3.48
2.48
1.4
1.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
490
4383
1.20
2.47
3.7
3.6
estimate
0.0
0.0
0.00
105
815
(3027801) Oxygen [Partial pressure] in Arterial blood
152
1193
1.31
2.47
5.7
8.2
kpa
12.1
11.9
0.16
146
1147
(3014111) Lactate [Moles/volume] in Serum or Plasma
121
919
1.35
2.45
5.0
7.8
mmol/l
1.5
1.4
0.04
114
885
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
21
103
2.06
2.42
1.7
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
20
97
2.08
2.38
1.8
1.3
nmol/l
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
860
8119
1.22
2.37
16.9
16.9
%
39.9
40.1
0.14
572
5617
(4010399)
89
647
1.41
2.36
1.5
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
151
1192
1.31
2.36
5.7
8.3
mmol/l
1.4
1.2
0.36
121
929
(3051611) Lipemic interference index of Serum or Plasma
19
91
2.11
2.33
2.8
4.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
344
2995
1.21
2.28
3.7
3.5
u/l
30.1
35.0
2.13
326
2848
(3019225) pH of Specimen
121
933
1.33
2.24
4.5
4.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
166
1343
1.27
2.16
1.2
1.2
u/ml
17.3
10.9
0.32
52
497
(3052851) Hemolysis interference index of Serum or Plasma
45
291
1.57
2.14
3.8
3.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
301
2604
1.21
2.12
3.6
3.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
25
138
1.83
2.10
2.8
2.7
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
14
62
2.27
2.08
2.4
4.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
40
254
1.59
2.06
1.2
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
80
587
1.39
2.04
1.6
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
18
90
2.02
2.01
1.9
1.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
93
703
1.35
1.98
3.5
5.2
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
65
464
1.42
1.95
1.5
1.9
g/l
1.7
1.5
1.07
55
410
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
8
27
2.98
1.94
2.5
2.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
84
628
1.36
1.93
2.0
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
636
5903
1.17
1.92
3.8
3.3
u/l
65.0
55.8
0.68
591
5486
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29
173
1.69
1.91
2.0
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
78
578
1.37
1.89
2.7
2.7
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
91
692
1.34
1.88
3.3
4.1
%
0.5
0.5
0.09
26
182
(3000991) Gas panel - Venous blood
111
869
1.31
1.87
5.8
9.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
145
1182
1.26
1.79
2.2
1.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
129
1037
1.27
1.79
1.5
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
67
490
1.39
1.77
1.6
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
145
1184
1.26
1.77
2.2
1.9
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
96
744
1.32
1.76
3.2
2.9
ml/min/173m2
82.2
65.5
0.64
43
307
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
60
432
1.41
1.74
1.8
2.0
ug/l
3.1
2.0
0.31
54
385
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
9
36
2.51
1.74
2.8
2.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
295
2593
1.18
1.72
3.0
2.9
umol/l
5038.7
6049.0
0.14
253
2239
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
13
61
2.14
1.72
1.1
1.3
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
18
96
1.89
1.71
1.9
3.9
%
63.1
53.2
1.08
11
70
(3001019) Free T4 and TSH panel - Serum or Plasma
19
330
0.57
1.68
1.7
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
25
149
1.69
1.67
5.6
3.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
25
149
1.69
1.67
2.2
1.7
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
16
83
1.94
1.65
1.1
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
22
127
1.75
1.65
4.3
2.2
u/l
384.1
8002.8
—
9
38
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38
253
1.52
1.64
1.9
1.7
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
117
941
1.27
1.63
3.2
3.9
mmol/l
1.9
2.0
0.01
99
743
(3010813) Leukocytes [#/volume] in Blood
1029
9994
1.23
1.62
28.0
22.9
e9/l
7.1
6.8
1.92
1007
9685
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
25
151
1.67
1.60
1.7
1.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1028
9986
1.23
1.60
28.1
22.8
e9/l
246.0
242.0
1.03
1009
9707
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
26
159
1.65
1.60
1.0
1.4
—
—
—
0
0
(3024731) MCV [Entitic volume]
1028
9988
1.23
1.58
27.9
22.8
fl
91.3
91.3
0.03
1015
9817
(3035941) MCH [Entitic mass]
1028
9989
1.23
1.57
27.9
22.7
pg
30.4
30.4
0.34
1015
9816
(3026361) Erythrocytes [#/volume] in Blood
1028
9990
1.23
1.57
28.0
22.8
e12/l
4.5
4.5
1.42
1005
9682
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
137
1.69
1.56
2.1
1.6
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1028
9992
1.23
1.55
28.2
23.0
g/l
135.0
136.3
1.89
1016
9821
(3014051) Protein [Presence] in Urine by Test strip
31
200
1.56
1.55
2.6
2.1
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
42
0.00
1.52
0.0
2.2
—
52.6
—
0
34
(3021589) Normoblasts [#/volume] in Blood
436
3985
1.15
1.52
11.8
10.0
e9/l
0.0
0.0
1.14
367
3232
(40761511) CBC panel - Blood by Automated count
967
9353
1.19
1.50
17.9
14.8
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
32
210
1.54
1.49
3.7
2.7
%
15.7
16.0
0.11
15
110
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
202
1742
1.19
1.47
1.3
1.2
u/ml
1.3
1.4
0.14
61
462
(3017181) Myelocytes/100 leukocytes in Blood
96
765
1.28
1.46
3.3
4.2
%
0.6
0.9
1.09
35
248
(3038177) Helicobacter pylori Ab [Presence] in Serum
18
102
1.78
1.45
1.2
1.3
—
—
—
0
0
(4133840)
6
22
2.74
1.43
2.0
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
90
714
1.28
1.42
3.4
4.4
%
0.2
0.1
0.08
33
225
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
23
141
1.64
1.42
1.0
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
54
398
1.37
1.41
1.2
1.2
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
115
942
1.24
1.40
3.1
3.9
kpa
5.8
5.9
0.08
109
915
(3020779) Urea [Moles/volume] in Serum or Plasma
115
942
1.24
1.40
6.9
7.8
mmol/l
9.5
10.3
0.71
109
898
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
50
365
1.39
1.39
1.0
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
41
2.20
1.37
3.7
4.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
915
8830
1.16
1.36
5.2
4.7
mmol/l
6.1
6.1
0.08
831
7985
(3045424) Erythrocytes [Presence] in Urine
25
159
1.58
1.35
1.2
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
72
559
1.31
1.35
7.0
11.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
86
684
1.28
1.35
2.1
2.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
38
0.00
1.34
0.0
1.0
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
113
929
1.24
1.34
2.9
2.3
g/l
0.2
0.2
0.82
108
863
(3047181) Lactate [Moles/volume] in Blood
45
325
1.40
1.33
4.4
7.7
mmol/l
1.1
1.3
2.89
39
283
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
22
136
1.63
1.33
1.9
1.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
772
7371
1.14
1.31
20.9
19.2
%
13.9
13.8
1.90
762
7206
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
38
267
1.44
1.31
2.2
2.5
ug/min
110.5
103.1
0.05
20
161
(3000492) Spirometry study
107
877
1.24
1.31
1.6
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
371
3384
1.14
1.30
4.1
3.8
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
14
76
1.85
1.30
3.1
2.1
e9/l
1.3
1.2
—
8
44
(3041096) Erythrocytes [Presence] in Urine by Automated
263
2344
1.16
1.28
3.2
3.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
19
114
1.68
1.28
2.5
1.8
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
37
260
1.44
1.28
1.1
1.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
151
1288
1.20
1.25
5.4
7.4
mmol/l
104.3
104.2
0.07
146
1256
(3025159) Blasts/100 leukocytes in Blood
84
673
1.27
1.25
3.6
4.4
%
0.0
0.1
0.53
28
190
(3006442) Creatine [Moles/volume] in Serum or Plasma
13
70
1.87
1.24
1.2
1.6
—
73.2
—
0
5
(42529406) Shigella sp [Presence] in Stool by Culture
37
262
1.43
1.24
1.1
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
121
1013
1.22
1.22
1.5
1.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
92
748
1.25
1.22
4.8
3.9
mmol/l
1.2
1.2
0.75
85
651
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
108
894
1.23
1.22
2.3
2.5
u/l
29.6
37.0
0.71
80
763
(3049717) Cytology report of Urine Cyto stain
59
453
1.32
1.22
3.1
2.8
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
19
2.64
1.21
1.0
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
876
8454
1.14
1.20
6.6
6.1
mmol/mol
40.1
40.4
0.51
808
7768
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
18
109
1.66
1.19
7.2
4.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
14
79
1.78
1.17
2.3
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
34
240
1.43
1.17
2.0
1.7
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
18
110
1.65
1.15
1.1
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
36
0.00
1.14
0.0
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
39
286
1.38
1.10
1.6
1.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
25
169
1.49
1.07
1.2
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
36
262
1.39
1.06
1.1
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
89
734
1.23
1.06
1.9
1.6
—
—
—
0
0
(4015189)
7
33
2.13
1.05
1.9
2.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
781
7510
1.12
1.05
23.2
20.4
g/l
332.7
332.8
0.21
775
7449
(3008401) Mugwort IgE Ab [Units/volume] in Serum
16
98
1.64
1.03
1.1
1.1
u/ml
0.2
1.1
—
7
46
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
22
2.28
1.03
1.4
1.5
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
11
60
1.84
1.03
1.0
1.2
mmol/l
10.4
12.9
—
6
21
(3008757) Leukocyte morphology finding [Identifier] in Blood
18
114
1.59
1.03
1.6
4.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
29
205
1.43
1.01
1.3
1.6
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
16
99
1.62
1.00
1.2
1.1
u/ml
3.6
5.9
—
9
54
(4034850)
19
285
0.66
1.00
18.8
12.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
7
35
2.01
1.00
1.0
1.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
23
2.18
0.98
3.2
3.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
25
173
1.45
0.98
2.2
1.8
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
9
50
1.81
0.96
2.8
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
328
3022
1.12
0.96
3.9
3.2
mmol/l
7.4
7.9
1.36
275
2492
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
0
31
0.00
0.96
0.0
3.9
—
71.8
—
0
26
(3006462) Nitrate [Presence] in Urine
7
37
1.90
0.94
4.6
2.8
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
7
37
1.90
0.94
1.4
2.7
u/l
170.7
214.0
—
7
37
(3035637) Corticotropin [Mass/volume] in Plasma
16
101
1.59
0.94
1.4
1.6
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
27
2.23
0.93
1.8
1.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
73
600
1.23
0.92
3.4
3.3
e9/l
4.9
4.1
1.01
54
457
(3017143) Hepatitis C virus Ab [Presence] in Serum
105
895
1.19
0.92
1.5
1.6
—
—
—
0
0
(44813793)
9
52
1.74
0.92
1.1
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
230
2081
1.13
0.92
3.9
3.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
13
78
1.67
0.91
1.4
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
18
267
0.67
0.91
1.1
1.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
41
314
1.32
0.91
2.3
1.8
nmol/l
32.2
40.1
2.65
41
301
(3005570) Glucose [Moles/volume] in Urine
5
102
0.49
0.89
1.8
2.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
57
703
0.80
0.88
1.3
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
17
111
1.54
0.88
1.1
1.1
u/ml
0.5
1.9
—
8
53
(3048929) Epstein Barr virus Ab [Presence] in Serum
33
246
1.35
0.88
1.2
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
25
178
1.41
0.86
1.1
1.7
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
8
44
1.82
0.86
1.0
1.1
iu/ml
520.8
250.0
—
8
44
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
29
213
1.37
0.85
1.3
1.2
u/ml
1.8
6.1
—
5
28
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
69
571
1.22
0.84
2.1
1.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
95
814
1.18
0.81
4.1
3.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
311
2885
1.11
0.80
3.4
3.3
mg/l
273.3
296.1
0.04
210
1888
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
482
4568
1.09
0.79
5.2
4.9
ug/l
3.1
3.8
0.23
430
4069
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
49
393
1.26
0.79
2.7
2.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
49
393
1.26
0.79
2.7
2.4
g/l
3.6
3.9
0.97
35
292
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
49
393
1.26
0.79
2.7
2.4
g/l
6.9
7.3
1.07
36
303
(3020650) Glucose [Presence] in Urine
6
33
1.82
0.79
1.5
1.3
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
11
66
1.67
0.79
1.2
1.0
u/ml
0.4
0.4
—
5
21
(3043410) Blood group antigens tested for on Red Blood Cells
6
34
1.77
0.76
2.2
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
16
107
1.50
0.76
1.3
1.8
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
14
91
1.54
0.75
1.1
1.1
u/ml
0.2
5.3
—
7
27
(21494814) CD8 cells/100 lymphocytes in Specimen
5
24
2.09
0.74
2.4
1.9
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
5
24
2.09
0.74
1.4
2.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
25
2.00
0.72
2.6
1.7
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
11
68
1.62
0.72
1.2
1.1
u/ml
0.5
4.3
—
6
30
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
12
76
1.58
0.71
1.5
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
46
372
1.25
0.71
2.8
2.5
g/l
2.8
3.1
1.57
35
295
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
45
364
1.25
0.70
2.8
2.5
g/l
9.8
10.8
0.78
37
313
(3013139) Helicobacter pylori Ag [Presence] in Stool
62
520
1.20
0.69
1.2
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
13
85
1.54
0.69
1.8
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
27
1.86
0.68
1.4
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
5
27
1.86
0.68
1.2
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
15
102
1.48
0.67
1.3
1.8
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
17
119
1.43
0.67
1.2
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
43
1.63
0.67
2.6
1.7
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
43
1.63
0.67
5.0
6.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
71
606
1.18
0.66
1.6
1.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
79
681
1.17
0.66
2.9
3.9
ng/l
82.4
93.8
0.65
70
599
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
124
1106
1.14
0.65
2.0
1.9
%
1.5
1.6
0.10
109
946
(4211845)
7
44
1.59
0.65
4.6
2.7
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
10
62
1.62
0.65
1.3
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
10
62
1.62
0.65
1.3
1.4
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
5
29
1.73
0.64
3.0
4.9
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
5
29
1.73
0.64
1.2
1.0
—
7.4
—
0
6
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
904
8849
1.09
0.63
4.7
4.5
mmol/l
1.4
1.4
1.97
835
8079
(1761482) Bacteria [#/volume] in Urine by Culture
18
246
0.73
0.63
3.1
4.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
8
49
1.64
0.62
1.9
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
129
1159
1.13
0.61
10.6
7.8
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
5
30
1.67
0.61
1.0
1.2
—
4.1
—
0
13
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
50
1.60
0.61
3.0
1.6
—
—
—
0
0
(3020891) Body temperature
50
417
1.21
0.61
4.0
4.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
52
1.54
0.59
1.3
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
52
1.54
0.59
1.3
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
52
1.54
0.59
1.3
1.7
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
52
1.54
0.59
4.1
2.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
52
1.54
0.59
1.3
1.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
927
9093
1.09
0.59
5.3
5.1
mmol/l
2.7
2.7
0.10
855
8296
(3036048) Francisella tularensis Ab [Titer] in Serum
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
11
72
1.53
0.59
1.7
2.0
e6/l
416.7
716.3
—
6
27
(3017315) Amylase [Enzymatic activity/volume] in Urine
8
53
1.51
0.58
1.4
1.3
u/l
145.3
467.2
—
8
48
(3028707) Methadone [Presence] in Urine by Screen method
15
106
1.42
0.57
6.3
2.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
323
3049
1.08
0.57
4.2
4.0
mg/mmol
9.1
9.3
0.02
218
1975
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
38
462
0.82
0.57
1.8
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
55
1.46
0.56
1.4
1.6
—
—
—
0
0
(44790049)
17
124
1.38
0.56
1.9
1.7
—
—
—
0
0
(44790048)
17
124
1.38
0.56
1.9
1.7
—
—
—
0
0
(44806118)
17
124
1.38
0.56
1.9
1.7
—
—
—
0
0
(44790047)
17
124
1.38
0.56
1.9
1.7
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
55
468
1.18
0.55
1.9
2.9
%
0.6
0.7
0.97
55
455
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
13
90
1.45
0.55
1.2
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
23
177
1.31
0.55
1.1
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
38
1.58
0.54
1.2
1.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
33
267
1.24
0.54
1.8
1.6
iu/ml
0.1
23.2
—
6
52
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
61
1.48
0.53
2.7
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
103
1147
0.89
0.53
4.8
4.6
%
31.3
31.6
0.10
76
755
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
22
169
1.31
0.53
1.1
1.1
u/ml
198.9
287.9
1.32
15
100
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
909
8923
1.08
0.53
4.8
4.6
mmol/l
4.5
4.5
0.14
848
8204
(3023183) Ammonium ion [Moles/volume] in Plasma
31
250
1.25
0.52
4.9
3.1
umol/l
36.7
33.9
0.26
25
205
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
16
117
1.37
0.52
1.5
1.5
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
43
361
1.20
0.51
1.1
1.1
—
24.5
—
0
8
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
10
145
0.69
0.50
1.3
1.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
65
1.39
0.50
1.0
1.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
13
92
1.42
0.50
1.1
1.3
u/l
51.4
52.7
—
8
67
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
16
118
1.36
0.50
1.9
2.3
mg/l
12.2
20.7
—
6
24
(3034860) Kappa light chains.free [Mass/volume] in Serum
39
325
1.21
0.50
2.9
3.6
mg/l
48.7
77.6
0.74
29
266
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
39
325
1.21
0.50
2.9
3.6
mg/l
26.3
47.6
1.39
30
267
(3027456) Digoxin [Moles/volume] in Serum or Plasma
27
216
1.26
0.49
3.3
3.1
nmol/l
0.8
0.9
1.01
20
171
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
45
1.56
0.49
1.3
1.3
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
7
108
0.65
0.48
1.1
2.0
—
1552.0
—
0
5
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
215
2012
1.08
0.48
1.7
1.7
pmol/l
56322269.1
28979763.8
0.20
174
1646
(40768800) Prostate Pathology biopsy report
22
278
0.79
0.48
1.1
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
92
826
1.12
0.47
2.3
2.7
g/l
66.5
66.4
0.05
84
753
(3024354) Oxygen [Partial pressure] in Venous blood
87
780
1.12
0.46
2.5
3.1
kpa
4.6
4.5
0.11
81
754
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
111
1010
1.11
0.46
3.4
4.3
ug/l
10.5
26.5
0.86
91
847
(36660697) Celiac disease serology panel - Serum
67
591
1.14
0.45
1.2
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
50
1.40
0.45
1.3
1.3
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
36
302
1.20
0.44
1.8
1.8
mg/l
3.8
3.2
0.12
21
225
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
873
8579
1.07
0.44
4.3
4.1
mmol/l
1.4
1.3
2.92
805
7787
(21494890) Protein electrophoresis panel - 24 hour Urine
14
104
1.35
0.43
1.8
2.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
11
78
1.41
0.43
2.9
3.6
%
10.1
11.1
0.31
11
78
(3023323) Follitropin [Units/volume] in Serum or Plasma
27
221
1.23
0.42
1.3
1.4
iu/l
35.0
26.6
0.59
21
193
(3051387) C reactive protein [Mass/volume] in Capillary blood
25
203
1.24
0.42
3.2
3.7
mg/l
28.8
28.5
0.01
17
128
(44816559) Phosphatidylethanol [Mass/volume] in Blood
22
176
1.25
0.42
1.6
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
19
149
1.28
0.42
1.2
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
29
240
1.21
0.41
2.4
3.9
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
5
33
1.52
0.41
1.6
1.1
—
25.4
—
0
5
(40765089) Chromosome analysis panel - Blood by G-banded
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
16
0.00
0.41
0.0
1.1
—
28.6
—
0
10
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
74
824
0.89
0.41
1.5
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
8
59
1.36
0.41
3.3
2.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
8
59
1.36
0.41
1.4
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
71
635
1.13
0.40
2.2
1.9
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
25
205
1.22
0.39
3.8
3.8
u/ml
45.8
1475.6
0.64
20
193
(3045788) Cell count panel - Pleural fluid
7
106
0.66
0.39
1.0
1.4
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
0
19
0.00
0.39
0.0
1.1
—
1.3
—
0
14
(3042010) Triglyceride [Moles/volume] in Pleural fluid
0
19
0.00
0.39
0.0
1.1
—
0.7
—
0
14
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
15
115
1.31
0.39
1.5
1.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
36
1.39
0.38
3.6
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
54
477
1.14
0.38
1.2
1.2
iu/ml
46.2
141.1
2.77
16
183
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
9
70
1.29
0.36
1.0
1.8
nmol/l
16.3
19.6
—
9
63
(3024522) Salmonella sp identified in Specimen by Organism specific culture
15
117
1.29
0.35
1.5
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
124
0.72
0.35
1.0
1.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
97
892
1.10
0.35
2.4
2.2
nmol/l
11.5
13.2
1.42
84
789
(1001926) Buprenorphine [Presence] in Urine by Screen method
21
172
1.22
0.34
7.6
2.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
11
82
1.34
0.34
1.1
1.2
—
—
—
0
0
(4062490)
11
82
1.34
0.34
1.8
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
45
1.33
0.33
1.2
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
63
697
0.90
0.33
1.9
1.8
—
—
—
0
0
(3000012) Reticulocyte production index
6
46
1.31
0.33
1.7
2.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
378
3655
1.05
0.32
4.9
4.3
%
24.0
21.3
2.60
170
1771
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
17
137
1.24
0.32
1.4
1.1
g/l
1.6
1.5
0.04
17
124
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
12
92
1.31
0.32
1.2
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
12
92
1.31
0.32
1.2
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
12
92
1.31
0.32
1.2
1.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
30
258
1.17
0.31
1.3
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
239
2287
1.06
0.31
1.7
1.6
nmol/l
19.1
20.1
0.46
214
1948
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
7
53
1.32
0.31
1.9
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
22
261
0.84
0.30
1.2
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
11
84
1.31
0.30
1.4
1.2
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
7
56
1.25
0.29
1.1
1.2
mmol/l
27.1
33.4
—
7
51
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
253
2430
1.05
0.29
1.5
1.7
mmol/l
1.4
1.4
0.42
206
2017
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
255
2652
0.95
0.28
2.9
3.1
ug/l
0.7
0.8
0.61
164
1759
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
11
85
1.30
0.28
2.2
2.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
8
62
1.29
0.28
1.1
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
8
62
1.29
0.28
1.1
1.7
—
—
—
0
0
(3017704) Immunofixation for Urine
8
62
1.29
0.28
1.4
1.8
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
23
196
1.18
0.27
2.0
2.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
35
309
1.14
0.27
1.2
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
8
66
1.21
0.26
1.4
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
85
913
0.93
0.26
1.7
1.6
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
71
0.70
0.26
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
71
0.70
0.26
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
71
0.70
0.26
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
71
0.70
0.26
1.4
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
24
207
1.16
0.25
7.3
2.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
14
170
0.82
0.25
1.1
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
9
75
1.20
0.25
1.2
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
28
245
1.15
0.25
2.1
2.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
43
388
1.11
0.24
1.4
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
25
217
1.16
0.24
2.0
3.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
19
161
1.18
0.24
1.1
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
81
0.74
0.24
1.3
1.5
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
38
1.32
0.23
1.2
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
19
162
1.18
0.23
3.4
3.7
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
11
88
1.25
0.22
1.0
1.2
nmol/l
1.2
1.5
0.89
11
80
(3008037) Lactate [Moles/volume] in Venous blood
18
210
0.85
0.22
3.6
3.4
mmol/l
1.4
1.5
0.38
18
204
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
41
1.22
0.22
1.0
1.1
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
41
1.22
0.22
2.6
2.4
%
79.0
99.6
—
5
41
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
107
1.22
0.21
3.5
2.7
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
42
1.19
0.21
1.2
1.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
10
0.00
0.21
0.0
5.3
—
—
—
0
0
(44806071)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
7.8
—
0.4
—
0
12
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
43
1.16
0.21
1.4
1.3
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.7
—
61.3
—
0
5
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
24
211
1.14
0.20
1.5
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
10
80
1.25
0.20
1.1
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
48
1.25
0.20
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
48
1.25
0.20
1.0
1.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
31
279
1.11
0.19
1.7
1.5
ug/g
265.0
281.9
0.17
20
159
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
14
118
1.19
0.19
1.5
1.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
10
122
0.82
0.19
1.3
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
14
118
1.19
0.19
1.5
1.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
35
318
1.10
0.19
3.2
2.4
g/l
39.4
37.5
1.12
30
276
(3019150) Specific gravity of Urine by Refractometry
202
1954
1.04
0.19
4.8
4.0
kg/l
1.0
1.0
1.04
30
269
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
53
1.13
0.18
1.0
1.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
18
156
1.16
0.18
1.5
1.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
24
213
1.13
0.18
1.3
1.4
u/l
11.1
8.0
0.39
19
173
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
29
261
1.11
0.18
1.3
1.6
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
21
185
1.14
0.18
2.2
1.8
iu/l
5.7
5.6
—
9
54
(3021879) Hepatitis B virus core Ab [Presence] in Serum
61
571
1.07
0.18
1.3
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
14
119
1.18
0.17
1.5
1.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
62
1.13
0.17
1.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
63
1.11
0.17
2.1
2.6
—
—
—
0
0
(3004451) EKG impression Narrative
7
63
1.11
0.17
1.4
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
67
0.75
0.17
1.0
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
67
0.75
0.17
1.0
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
68
0.73
0.17
1.4
2.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
17
148
1.15
0.17
1.1
1.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
37
340
1.09
0.16
3.2
2.6
g/l
1.1
1.4
0.16
31
301
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
39
360
1.09
0.16
2.1
2.4
u/ml
0.3
0.4
0.33
22
202
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
71
1.13
0.16
1.0
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
11
92
1.20
0.16
1.1
1.1
—
—
—
0
0
(4024509)
6
79
0.76
0.15
1.5
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
78
1.16
0.15
1.0
1.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
20
178
1.13
0.15
1.6
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
25
226
1.11
0.15
7.1
2.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
25
226
1.11
0.15
7.2
2.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
49
459
1.07
0.15
3.1
3.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
88
0.79
0.14
1.1
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
11
93
1.18
0.14
1.1
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
17
150
1.14
0.14
1.5
1.4
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
28
256
1.10
0.14
2.5
2.1
mg/l
9.1
11.8
1.23
28
235
(3023410) Appearance of Cerebral spinal fluid
10
84
1.19
0.14
1.5
1.6
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
17
191
0.89
0.14
1.7
1.5
e6/l
3038.6
728.7
0.65
12
157
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
17
191
0.89
0.14
1.6
1.4
e6/l
12.0
52.0
0.68
12
152
(4094501)
23
253
0.91
0.13
1.1
1.1
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
9
110
0.82
0.13
1.2
1.4
mmol/l
6.6
6.4
—
9
104
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
22
200
1.10
0.12
7.7
6.8
iu/ml
112.0
946.6
—
5
34
(3038515) Glucose [Moles/volume] in Venous blood
18
199
0.90
0.11
3.6
3.5
mmol/l
7.8
7.6
0.19
18
194
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
51
484
1.06
0.11
5.8
4.3
mmol/l
23.6
24.0
0.34
45
439
(3039443) Prostate specific Ag panel - Serum or Plasma
22
240
0.92
0.11
1.8
1.7
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
15
134
1.12
0.11
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
15
134
1.12
0.11
1.1
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
22
239
0.92
0.10
1.6
1.6
e6/l
8771.5
13825.6
0.35
15
177
(3000764) Benzodiazepines [Presence] in Urine
24
222
1.08
0.10
7.4
2.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
242
2378
1.02
0.10
1.4
1.4
—
—
—
0
0
(4306422)
14
126
1.11
0.09
1.4
1.2
—
—
—
0
0
(4027681)
6
54
1.11
0.09
1.3
1.2
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
6
56
1.07
0.08
1.0
1.2
u/l
83.7
80.3
—
6
50
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
5
61
0.82
0.08
1.0
1.3
—
69.0
—
0
10
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
5
60
0.83
0.08
1.2
1.6
u/l
4.2
7.7
—
5
47
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
16
146
1.10
0.08
1.0
1.1
iu/ml
9.0
73.4
—
5
31
(3035880) pH of Pleural fluid
5
64
0.78
0.08
1.2
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
29
274
1.06
0.07
1.6
1.7
—
—
—
0
0
(4146454)
10
112
0.89
0.07
2.5
2.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
86
1.05
0.07
1.6
1.7
—
—
—
0
0
(4268621)
9
86
1.05
0.07
2.3
2.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
14
128
1.09
0.06
1.4
1.2
u/ml
2.3
5.8
—
8
57
(3027944) Amphetamines [Presence] in Urine
24
226
1.06
0.06
7.5
2.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
34
356
0.95
0.06
3.0
3.7
g/l
0.4
0.2
0.79
17
152
(3017817) Protein [Mass] in Urine collected for unspecified duration
9
101
0.89
0.06
4.0
2.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
11
121
0.91
0.06
2.0
2.7
—
—
—
0
0
(1002224) Polysomnography panel
38
365
1.04
0.06
1.1
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
24
227
1.06
0.06
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
24
227
1.06
0.06
1.4
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
15
139
1.08
0.05
1.8
1.5
g/l
0.6
0.8
—
10
106
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
22
208
1.06
0.05
1.2
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
11
100
1.10
0.05
1.1
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
48
466
1.03
0.04
1.4
1.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
15
143
1.05
0.01
1.1
1.3
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
18
173
1.04
0.01
1.1
1.2
u/l
109.8
43.4
0.54
11
148
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
25
244
1.03
0.00
1.4
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
124
0.97
0.00
1.2
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
13
126
1.03
0.00
1.2
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
27
266
1.02
0.00
1.5
2.0
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
10
98
1.02
0.00
1.4
1.2
mmol/l
7.6
7.8
—
10
64
(3044927) Protein electrophoresis panel - Urine
11
108
1.02
0.00
1.1
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
310
3104
1.00
0.00
2.9
2.9
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
18
181
0.99
0.00
1.3
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
10
103
0.97
0.00
1.0
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
12
117
1.03
0.00
1.3
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
18
177
1.02
0.00
1.3
1.3
miu/ml
285.8
227.9
—
5
77
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
21
213
0.99
0.00
1.9
1.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
14
145
0.97
0.00
1.2
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
12
125
0.96
0.00
1.2
1.5
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
75
0.93
0.00
1.4
1.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
8
86
0.93
0.00
1.3
1.4
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
59
0.85
0.00
2.2
1.9
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
21
210
1.00
0.00
1.3
1.3
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
8
82
0.98
0.00
1.0
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
60
1.00
0.00
1.2
1.6
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
62
0.97
0.00
2.0
2.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
63
0.95
0.00
2.5
1.6
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
7
72
0.97
0.00
1.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
(3013762) Body weight Measured
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
6
0.00
0.00
0.0
4.7
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
66
0.91
0.00
1.7
1.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
54
0.93
0.00
2.0
2.9
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
0
7
0.00
0.00
0.0
1.0
—
5.5
—
0
7
(3001729) Color of Synovial fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(4281824)
7
77
0.91
0.00
1.0
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
54
0.93
0.00
1.4
1.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
57
0.88
0.00
6.4
2.9
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
69
1.01
0.00
1.0
1.2
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
17
170
1.00
0.00
1.6
1.4
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.6
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
8
0.00
0.00
0.0
2.1
—
1.6
—
0
8
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
5
54
0.93
0.00
1.0
1.2
u/l
7.4
17.4
—
5
47
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
54
0.93
0.00
1.4
1.4
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
7
0.00
0.00
0.0
1.0
—
0.1
—
0
7
(3030313) Adrenal Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
70
1.00
0.00
1.1
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
87
0.92
0.00
1.5
1.3
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
50
1.00
0.00
6.4
16.9
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
5
56
0.89
0.00
10.2
18.3
nmol/l
1465.8
1500.4
—
5
56
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3025315) Body weight
0
8
0.00
0.00
0.0
3.1
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_LARYNX and mortality.

Females

Parameter HR [95% CI] p-value
CD2_BENIGN_LARYNX 1.44 [1.24, 1.67] < 0.001
Birth year 0.999 [0.99, 1.01] 0.792

During the follow-up period (1.1.1998 — 31.12.2019), 365 out of 1646 females with CD2_BENIGN_LARYNX died.

Males

Parameter HR [95% CI] p-value
CD2_BENIGN_LARYNX 1.766 [1.57, 1.99] < 0.001
Birth year 0.985 [0.97, 0.99] 0.002

During the follow-up period (1.1.1998 — 31.12.2019), 973 out of 3146 males with CD2_BENIGN_LARYNX died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_LARYNX.

N-year risk Females Males
1 0.172% 0.328%
5 1.02% 1.903%
10 2.305% 4.549%
15 4.399% 8.697%
20 7.596% 14.442%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_LARYNX – Benign neoplasm: Larynx

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data